Mo1219 Prevalence of Abdominal Pain (AP) Related Functional Gastrointestinal Disorders (FGIDs) in Pediatric Recipients of Hematopoietic Stem Cell Transplant (HSCT)
Miguel Saps(University of Miami), Sonali Chaudhury(Northwestern University), Kimberley Dilley(Northwestern University), Morris Kletzel(Lurie Children's Hospital), Karina Danner‐Koptik(Lurie Children's Hospital), Larisa Broglie(Morgan Stanley Children's Hospital)
Cited by 0
Related Papers
Health-Related Quality of Life in Pediatric Patients with Functional and Organic Gastrointestinal Diseases
|The Journal of Pediatrics|2014|277
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
|Transplantation and Cellular Therapy|2012|201
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
|Transplantation and Cellular Therapy|2020|201
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2021|183